Targeted Oxygen for Initial Resuscitation of Preterm Infants
JAMA · 10.02.2026 · 335 (6) · 523
DOI: 10.1001/jama.2025.23327 ↗Kurz gefasst
Klinische Studie (Phase III) in der Zeitschrift JAMA, erschienen am 10.02.2026. Verfasst von Ju Lee Oei und 44 weiteren Autor:innen. Beteiligte Einrichtung: NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia. Hauptthemen laut MEDLINE: Brain Injuries, Infant, Extremely Premature, Oxygen Inhalation Therapy, Premature Birth. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Neonatologie, Reanimation
Abstract (Originalsprache)
Importance The most effective initial fraction of inspired oxygen (F io 2 ) for resuscitating preterm newborns is unknown.
Objective
To compare outcomes of newborns born at 23 to 28 weeks’ gestation resuscitated with initial F io 2 of 0.6 vs 0.3. Design, Setting, and Participants Randomized clinical trial conducted in 31 maternity hospitals in 6 countries. Consent by waiver was obtained in Australia, certain institutions in India, and Malaysia; prospective informed consent was obtained in certain institutions in India and all institutions in Singapore, Spain, and the US. Infants due at 23 to 28 weeks’ gestation were randomized shortly before birth. Those with congenital abnormalities affecting oxygenation, neurodevelopment, or survival were excluded. Randomization was conducted from September 2018 to September 2024, with follow-up expected to close in September 2026.
Intervention
Infants were randomized (1:1) to receive an initial F io 2 of 0.6 or 0.3; F io 2 was titrated to meet standard targets for oxygen saturation by pulse oximetry in the first 10 minutes or for clinical needs. Clinicians and those assessing outcomes were not blinded to group assignment. Main Outcomes and Measures The primary outcome was death and brain injury at 36 weeks’ corrected gestational age; secondary outcomes were the individual components of the primary outcome.
Results
A total of 1641 newborns were randomized. The primary analysis included 728 newborns randomized to receive an F io 2 of 0.6 and 741 to an F io 2 of 0.3 after excluding 172 newborns, mostly for birth after 28 weeks’ gestation and transfer to another hospital before birth (54% female). Rates of escalation to F io 2 of 1.0 were similar between the groups (F io 2 of 0.6: 41%; F io 2 of 0.3: 38%). Primary outcome information was ascertained in 1423 newborns (96.9%). Death or brain injury at 36 weeks’ corrected gestational age occurred in 330 of 703 newborns (46.9%) assigned to the F io 2 of 0.6 group vs 344 of 720 (47.8%) assigned to the F io 2 of 0.3 group (relative risk, 0.98 [95% CI, 0.89-1.09]). Conclusions and Relevance Initiating resuscitation of preterm infants with F io 2 of 0.6 vs 0.3 did not affect the risk of death or brain injury by 36 weeks’ corrected gestational age. These results lay a foundation for future trials evaluating the effectiveness and safety of using higher initial F io 2 levels for preterm infant resuscitation. Trial Registration ANZCTR Identifier: ACTRN12618000879268
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- NHMRC Clinical Trials Centre, University of Sydney, Camperdown, New South Wales, Australia.
- Department of Newborn Care, the Royal Hospital for Women, Randwick, New South Wales, Australia.
- Discipline of Paediatrics and Child Health, School of Clinical Medicine, UNSW Sydney, Australia.
- Mater Research, South Brisbane, Queensland, Australia.
- Newborn Intensive Care Unit, Te Whatu Ora Waikato, Hamilton, New Zealand.
- Department of Neonatal Medicine, Royal Women's Hospital, Parkville, Victoria, Australia.
Zitieren
APA
Oei, J. L., Kirby, A., Travadi, J., Davis, P., Wright, I., Ghadge, A., Yeung, C., Cruz, M., Keech, A., Hague, W., Lui, K., Vento, M., Gordon, A., De Waal, K., Chaudhari, T., Hong, T. S. L., Morris, S., Kushnir, A., Bonney, D., …, & TORPIDO30/60 Collaborative Group (2026). Targeted Oxygen for Initial Resuscitation of Preterm Infants. JAMA, 335(6), 523. https://doi.org/10.1001/jama.2025.23327
Vancouver
Oei JL, Kirby A, Travadi J, Davis P, Wright I, Ghadge A, et al. Targeted Oxygen for Initial Resuscitation of Preterm Infants. JAMA. 2026;335(6):523. doi:10.1001/jama.2025.23327
BibTeX
@article{Oei2026,
author = {Oei, Ju Lee and Kirby, Adrienne and Travadi, Javeed and Davis, Peter and Wright, Ian and Ghadge, Alpana and Yeung, Carbo and Cruz, Melinda and Keech, Anthony and Hague, Wendy and Lui, Kei and Vento, Maximo and Gordon, Adrienne and De Waal, Koert and Chaudhari, Tejasvi and Hong, Timothy Sui Loong and Morris, Scott and Kushnir, Alla and Bonney, Dennis and Tracy, Mark and Kumar, Kishore and Chhnia, Amitoj Singh and Baral, Vijay R and Muniyappa, Prasana and Cheah, Fook Choe and Sarnadgouda, Prashant and Rajadurai, Victor Samuel and Balakrishnan, Umamaheshwari and Oleti, Tejo Pratap and Aldecoa-Bilbao, Victoria and Couce, Maria-Luz and Collados, Caridad Tapia and Fernández, Raquel Escrig and Moliner, Elisender and Ruiz Gonzalez, Maria Dolores and Singhal, Mohit and Agrawal, Gopal and Singh, Jaykishore and Pal, Somalika and Nayya, Siddarth and Arora, Rohit and Amboiram, Prakash and Simes, John and Tarnow-Mordi, William and TORPIDO30/60 Collaborative Group, TORPIDO30/60 Collaborative Group},
title = {Targeted Oxygen for Initial Resuscitation of Preterm Infants},
journal = {JAMA},
year = {2026},
volume = {335},
number = {6},
pages = {523},
doi = {10.1001/jama.2025.23327}
}
EUVIMED